These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 30896454)

  • 21. Use of an intravenous port catheter for the delivery of intrathecal morphine in a terminally ill cancer patient with pain.
    Anwari JS; Romdhane K
    Neurosciences (Riyadh); 2020 Oct; 25(5):399-402. PubMed ID: 33459290
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The Relationship Between the Mechanisms of Action and Safety Profiles of Intrathecal Morphine and Ziconotide: A Review of the Literature.
    Webster LR
    Pain Med; 2015 Jul; 16(7):1265-77. PubMed ID: 25645109
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Optimizing Initial Intrathecal Drug Ratio for Refractory Cancer-Related Pain for Early Pain Relief. A Retrospective Monocentric Study.
    Dupoiron D; Leblanc D; Demelliez-Merceron S; Bore F; Seegers V; Dubois PY; Pechard M; Robard S; Delorme T; Jubier-Hamon S; Carvajal G; Lebrec N
    Pain Med; 2019 Oct; 20(10):2033-2042. PubMed ID: 31329956
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Spinal analgesia for severe cancer pain: A retrospective analysis of 60 patients.
    Kiehelä L; Hamunen K; Heiskanen T
    Scand J Pain; 2017 Jul; 16():140-145. PubMed ID: 28850391
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Acute rhabdomyolysis in a patient with long-term exposure to intrathecal ziconotide: a case report.
    Horazeck C; Huh AS; Huh BK
    Pain Pract; 2015 Mar; 15(3):E34-9. PubMed ID: 25565390
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The Role of Intrathecal Pumps in Nonmalignant Pain.
    Ginalis EE; Ali S; Mammis A
    Neurosurg Clin N Am; 2022 Jul; 33(3):305-309. PubMed ID: 35718400
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Using ziconotide for intrathecal infusions.
    Mitchell AA; Sapienza-Crawford AJ; Hanley KL; Lokey KJ; Wells L
    Nursing; 2008 Dec; 38(12):19. PubMed ID: 19033968
    [No Abstract]   [Full Text] [Related]  

  • 28. Intrathecal Pain Therapy for the Management of Chronic Noncancer Pain.
    Sukul VV
    Neurosurg Clin N Am; 2019 Apr; 30(2):195-201. PubMed ID: 30898270
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Intrathecal delivery of analgesics.
    De Andres J; Asensio-Samper JM; Fabregat-Cid G
    Methods Mol Biol; 2014; 1141():249-78. PubMed ID: 24567144
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Intrathecal ziconotide for refractory chronic pain.
    Lynch SS; Cheng CM; Yee JL
    Ann Pharmacother; 2006; 40(7-8):1293-300. PubMed ID: 16849624
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Rationale and Recent Advances in Targeted Drug Delivery for Cancer Pain: Is It Time to Change the Paradigm?
    Dupoiron D; Duarte R; Carvajal G; Aubrun F; Eldabe S
    Pain Physician; 2022 May; 25(3):E414-E425. PubMed ID: 35652767
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Retrospective Analysis of Intrathecal Drug Delivery: Outcomes, Efficacy, and Risk for Cancer-Related Pain at a High Volume Academic Medical Center.
    Sayed D; Monroe F; Orr WN; Phadnis M; Khan TW; Braun E; Manion S; Nicol A
    Neuromodulation; 2018 Oct; 21(7):660-663. PubMed ID: 29446171
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The Pharmacology of Spinal Opioids and Ziconotide for the Treatment of Non-Cancer Pain.
    Pope JE; Deer TR; Amirdelfan K; McRoberts WP; Azeem N
    Curr Neuropharmacol; 2017; 15(2):206-216. PubMed ID: 26861471
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Intrathecal ziconotide for neuropathic pain: a review.
    Rauck RL; Wallace MS; Burton AW; Kapural L; North JM
    Pain Pract; 2009; 9(5):327-37. PubMed ID: 19682321
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Initiation of Intrathecal Drug Delivery Dramatically Reduces Systemic Opioid Use in Patients With Advanced Cancer.
    Sindt JE; Odell DW; Dalley AP; Brogan SE
    Neuromodulation; 2020 Oct; 23(7):978-983. PubMed ID: 32459393
    [TBL] [Abstract][Full Text] [Related]  

  • 36. New aspects in performing interventional techniques for chronic pain.
    Zuurmond WW; Perez RS; Loer SA
    Curr Opin Support Palliat Care; 2007 Aug; 1(2):132-6. PubMed ID: 18685354
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Ziconotide for Management of Cancer Pain Refractory to Pharmacotherapy: An Update.
    Banik RK; Engle MP
    Pain Med; 2020 Dec; 21(12):3253-3259. PubMed ID: 32940675
    [No Abstract]   [Full Text] [Related]  

  • 38. Intrathecal betamethasone for cancer pain in the lower half of the body: a study of its analgesic efficacy and safety.
    Taguchi H; Oishi K; Sakamoto S; Shingu K
    Br J Anaesth; 2007 Mar; 98(3):385-9. PubMed ID: 17227818
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Intrathecal drug delivery for pain: a clinical guide and future directions.
    Pope JE; Deer TR
    Pain Manag; 2015; 5(3):175-83. PubMed ID: 25971641
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Intrathecal catheter granuloma associated with continuous sufentanil infusion.
    Gupta A; Martindale T; Christo PJ
    Pain Med; 2010 Jun; 11(6):847-52. PubMed ID: 20456073
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.